Insulet

PODD62

S&P500

$235.61arrow_drop_up1.87%$4.34

S&P500

PODD62

$235.61

arrow_drop_up1.87%$4.34

S&P500

Performance History

Key Stats
Open	$230.07
Prev. Close	$231.53
EPS	5.53
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	229.59	236.56
52 Week Range	125.82	243.98

Ratios







EPS	5.53

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Insulet (PODD)

Insulet Corp is a medical device company that develops and manufactures innovative insulin delivery systems for people with diabetes. The company's flagship product, the Omnipod Insulin Management System, is a wearable device that provides continuous insulin delivery without the need for traditional injections. This technology has revolutionized diabetes management, giving patients more freedom and flexibility in their daily lives. Insulet Corp has experienced significant growth in recent years, as the demand for its products continues to increase. The company's stock price has also performed well, with a steady upward trend over the past several years.

In addition to its strong financial performance, Insulet Corp has also received recognition for its innovative products. The company has won numerous awards for its Omnipod system, including the prestigious Medical Design Excellence Award. This recognition further validates the company's commitment to improving the lives of people with diabetes through advanced technology. Insulet Corp's market cap is currently around $9 billion, making it a major player in the medical device industry.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. James R. Hollingshead Ph.D.
Headquarters: Acton
Employees: 2600
Exchange: NASDAQ

Keep an eye on Insulet

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Insulet (PODD)?

For Insulet (PODD), the 52-week high is $243.98, which is 3.55% from the current price. The 52-week low is $125.82, the current price is 87.26% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Insulet's (PODD) price per share?

The current price per share for Insulet (PODD) is $235.61. The stock has seen a price change of $4.35 recently, indicating a 1.88% change. This reflects the stock's recent market performance and investor sentiment.

help

What is Insulet (PODD) stock price performance year to date (YTD)?

As of the latest data, Insulet (PODD) has a year-to-date price change of 12.67%. Over the past month, the stock has experienced a price change of 0.45%. Over the last three months, the change has been 19.45%. Over the past six months, the figure is 38.37%. Looking at a longer horizon, the five-year price change stands at 60.85%.

help

Is Insulet (PODD) a growth stock?

Insulet (PODD) has shown an average price growth of -2.03% over the past three years. It has received a score of 51 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Insulet as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Insulet (PODD) a profitable company?

Insulet (PODD) has a net income of $206.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.35% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 11.18% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.7B, with a revenue growth rate of 30.02%, providing insight into the company's sales performance and growth. The gross profit is $1.16B. Operating income is noted at $220M. Furthermore, the EBITDA is $381.8M.

help

What is the market capitalization of Insulet (PODD)?

Insulet (PODD) has a market capitalization of $16.52B. The average daily trading volume is 234.64, indicating the stock's liquidity and investor engagement.